AB 572
9 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Sponsors4 cosponsors more
Beth GainesCalifornia lawmaker · RAB 572
Diabetes prevention: treatment
California · In committee
Every link on this map
The same connections as a table, with the reason each one is here.
| Beth Gaines | Sponsors | Beth Gaines sponsored AB 572. | None |
| Association of California Healthcare Districts; the | Lobbied on it | Association of California Healthcare Districts; the named AB 572 in 7 lobbying reports. | 7 reports |
| California Kidney Care Alliance | Lobbied on it | California Kidney Care Alliance named AB 572 in 7 lobbying reports. | 7 reports |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Lobbied on it | Boehringer Ingelheim Pharmaceuticals, Inc. named AB 572 in 4 lobbying reports. | 4 reports |
| Medtronic, Inc. | Lobbied on it | Medtronic, Inc. named AB 572 in 3 lobbying reports. | 3 reports |
| Bayer U.S. LLC | Lobbied on it | Bayer U.S. LLC named AB 572 in 2 lobbying reports. | 2 reports |
| Biocom California | Lobbied on it | Biocom California named AB 572 in 2 lobbying reports. | 2 reports |
| California Life Sciences | Lobbied on it | California Life Sciences named AB 572 in 2 lobbying reports. | 2 reports |
| Sanofi US | Lobbied on it | Sanofi US named AB 572 in 2 lobbying reports. | 2 reports |